Results 201 to 210 of about 126,959 (266)

Beyond pigments and perfumes: engineering in the carotenoid and apocarotenoid spectrum, novel enzymes, and synthetic biology strategies. [PDF]

Front Bioeng Biotechnol
Ravi Gopal B, Wang ZQ.
europepmc   +1 more source

Multi-antigen MVA-vectored SARS-CoV-2 vaccine, GEO-CM04S1, induces cross-protective immune responses to ancestral and Omicron variants. [PDF]

Front Immunol
Elsharkawy A, Stone S, Guglani A, Wussow F, Burleson JD, Hauser M, Domi A, Kumari P, Albrecht TR, Dim C, Newman M, Diamond DJ, Oruganti SR, Kumar M.   +13 more
europepmc   +1 more source

Enhanced isoprenoid production in <i>Escherichia coli</i> cells harboring the archaeal mevalonate pathway. [PDF]

Biochem Biophys Rep
Takahashi T, Saito T, Dohgami I, Ito T, Hemmi H.   +4 more
europepmc   +1 more source

A Multi-Epitope Recombinant Vaccine Candidate Against Bovine Alphaherpesvirus 1 and 5 Elicits Robust Immune Responses in Mice and Rabbits. [PDF]

Vaccines (Basel)
Barbosa AAS, Pereira SH, Laguardia-Nascimento M, Ferrari AB, Cox LJ, Rocha RP, Leocádio VAT, Ribeiro ÁL, Lourenço KL, Da Fonseca FG, Barbosa-Stancioli EF.   +10 more
europepmc   +1 more source

MVA-BN-Brachyury-TRICOM Vaccine [PDF]

, 2020
openaire   +1 more source

Primary Care Providers' Perspectives of Knowledge and Skill Acquisition, and Benefits Following University Faculty-Led Continuing Medical Education Sessions: Results of a Qualitative Assessment in Southwest Uganda. [PDF]

Cureus
Mulogo E, Ntaro M, Turyakira E, Matte M, Wesuta A, Mwebembezi F, Agaba F, Nabimanya P, Tushabe A, Kawungezi P.   +9 more
europepmc   +1 more source

Mpox-Specific Neutralizing Antibodies up to 9 Months Following 1 or 2 Doses of Intradermal MVA-BN Vaccination in Sweden. [PDF]

Open Forum Infect Dis
Espinosa-Gongora C, Christ W, Mayola Danés N, Eichler-Jonsson C, Filén F, Storgärd E, Westergren V, Klingström J, Gredmark-Russ S, Johansen K, Ekström AM, Sondén K.   +11 more
europepmc   +1 more source

Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine. [PDF]

J Gen Virol
Pfranger M, Krause N, Asbach B, Meier J, Carnell G, Scheer L, Kalender A, Brenner D, Tonks P, Frost S, Wright E, Jordan I, Kennedy E, Hewson R, Blacklaws B, Chan A, Parthasarathy S, Dowall S, Carroll M, Sandig V, Fedosyuk S, Kinsley R, Heeney J, Wagner R.   +23 more
europepmc   +1 more source

Optimal deployment of limited vaccine supplies to control mpox outbreaks. [PDF]

NPJ Vaccines
Berry MT, MacIntyre CR, Cromer D, Hacker A, Davenport MP, Khoury DS.   +5 more
europepmc   +1 more source

STING-mediated antiviral response: insights into MVA replication control in avian cells. [PDF]

Microbiol Spectr
Brusco T, Menci V, Caiazza C, Petrone AM, Palladino R, Faticanti M, Bignone V, Ambrosino C, Scarselli E, Mallardo M, Siani L, Ruzza V.   +11 more
europepmc   +1 more source